Paying user area
Try for free
Shockwave Medical Inc. pages available for free this week:
- Balance Sheet: Liabilities and Stockholders’ Equity
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Enterprise Value (EV)
- Enterprise Value to EBITDA (EV/EBITDA)
- Enterprise Value to FCFF (EV/FCFF)
- Net Profit Margin since 2019
- Operating Profit Margin since 2019
- Debt to Equity since 2019
- Price to Operating Profit (P/OP) since 2019
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Shockwave Medical Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Income Statement
12 months ended: | Revenue | Income (loss) from operations | Net income (loss) |
---|---|---|---|
Dec 31, 2023 | |||
Dec 31, 2022 | |||
Dec 31, 2021 | |||
Dec 31, 2020 | |||
Dec 31, 2019 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Balance Sheet: Assets
Current assets | Total assets | |
---|---|---|
Dec 31, 2023 | ||
Dec 31, 2022 | ||
Dec 31, 2021 | ||
Dec 31, 2020 | ||
Dec 31, 2019 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Balance Sheet: Liabilities and Stockholders’ Equity
Shockwave Medical Inc., selected items from liabilities and stockholders’ equity, long-term trends
US$ in thousands
Current liabilities | Total liabilities | Total debt | Stockholders’ equity | |
---|---|---|---|---|
Dec 31, 2023 | ||||
Dec 31, 2022 | ||||
Dec 31, 2021 | ||||
Dec 31, 2020 | ||||
Dec 31, 2019 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Cash Flow Statement
12 months ended: | Net cash provided by (used in) operating activities | Net cash (used in) provided by investing activities | Net cash provided by (used in) financing activities |
---|---|---|---|
Dec 31, 2023 | |||
Dec 31, 2022 | |||
Dec 31, 2021 | |||
Dec 31, 2020 | |||
Dec 31, 2019 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Per Share Data
12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
---|---|---|---|
Dec 31, 2023 | |||
Dec 31, 2022 | |||
Dec 31, 2021 | |||
Dec 31, 2020 | |||
Dec 31, 2019 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.